185,95 €
185,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
93 °P sammeln
185,95 €
185,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
93 °P sammeln
Als Download kaufen
185,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
93 °P sammeln
Jetzt verschenken
185,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
93 °P sammeln
  • Format: PDF

The second edition of Neuroimmune Pharmacology bridges the disciplines of neuroscience, immunology and pharmacology from the molecular to clinical levels with particular thought made to engage new research directives and clinical modalities.
Bringing together the foremost field authorities from around the world, Neuroimmune Pharmacology will serve as an invaluable resource for the basic and applied scientists of the current decade and beyond.

  • Geräte: PC
  • ohne Kopierschutz
  • eBook Hilfe
  • Größe: 36.14MB
Produktbeschreibung
The second edition of Neuroimmune Pharmacology bridges the disciplines of neuroscience, immunology and pharmacology from the molecular to clinical levels with particular thought made to engage new research directives and clinical modalities.

Bringing together the foremost field authorities from around the world, Neuroimmune Pharmacology will serve as an invaluable resource for the basic and applied scientists of the current decade and beyond.


Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Howard E. Gendelman is the Margaret R. Larson Professor of Medicine and Chair of the Department of Pharmacology and Experimental Neuroscience and Director of the Center for Neurodegenerative Disorders at the University of Nebraska Medical Center. Tsuneya Ikezu is Professor in the Department of Pharmacology and Experimental Therapeutics at Boston University School of Medicine with joint appointments in the Department of Neurology and Boston University Alzheimer's Disease Center. He also leads the Laboratory of Molecular NeuroTherapeutics.